Rapid-Onset Myositis and Myocarditis Following Dual Immune Checkpoint Inhibitor Therapy With Nivolumab and Ipilimumab for Gastric Adenocarcinoma: A Case Report
Cureus · 14.05.2025
DOI: 10.7759/cureus.84121 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 14.05.2025. Verfasst von Steven B Barker und 1 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Northeast Georgia Medical Center Gainesville, Gainesville, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine, Northeast Georgia Medical Center Gainesville, Gainesville, USA.
Zitieren
APA
Barker, S. B., & Adewuyi, A. (2025). Rapid-Onset Myositis and Myocarditis Following Dual Immune Checkpoint Inhibitor Therapy With Nivolumab and Ipilimumab for Gastric Adenocarcinoma: A Case Report. Cureus. https://doi.org/10.7759/cureus.84121
Vancouver
Barker SB, Adewuyi A. Rapid-Onset Myositis and Myocarditis Following Dual Immune Checkpoint Inhibitor Therapy With Nivolumab and Ipilimumab for Gastric Adenocarcinoma: A Case Report. Cureus. 2025. doi:10.7759/cureus.84121
BibTeX
@article{Barker2025,
author = {Barker, Steven B and Adewuyi, Adeoluwa},
title = {Rapid-Onset Myositis and Myocarditis Following Dual Immune Checkpoint Inhibitor Therapy With Nivolumab and Ipilimumab for Gastric Adenocarcinoma: A Case Report},
journal = {Cureus},
year = {2025},
doi = {10.7759/cureus.84121}
}
EUVIMED